Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 297

    1.

    Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia.

    Deane AM, Nguyen NQ, Stevens JE, Fraser RJ, Holloway RH, Besanko LK, Burgstad C, Jones KL, Chapman MJ, Rayner CK, Horowitz M.

    J Clin Endocrinol Metab. 2009 Nov 5. [Epub ahead of print]PMID: 19892837 [PubMed - as supplied by publisher]Related articles

    2.

    The use of 4DCT to reduce lung dose: a dosimetric analysis.

    Khan F, Bell G, Antony J, Palmer M, Balter P, Bucci K, Chapman MJ.

    Med Dosim. 2009 Winter;34(4):273-8. Epub 2009 Jan 1.PMID: 19854385 [PubMed - in process]Related articles

    3.

    Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

    Chapman MJ, Le Goff W, Guerin M, Kontush A.

    Eur Heart J. 2009 Oct 12. [Epub ahead of print]PMID: 19825813 [PubMed - as supplied by publisher]Related articles

    4.

    HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis.

    Zerrad-Saadi A, Therond P, Chantepie S, Couturier M, Rye KA, Chapman MJ, Kontush A.

    Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2169-2175. Epub 2009 Sep 17.PMID: 19762782 [PubMed - as supplied by publisher]Related articles

    5.

    Evaluation of a bedside technique for postpyloric placement of feeding catheters.

    Deane AM, Fraser RJ, Young RJ, Foreman B, O'Conner SN, Chapman MJ.

    Crit Care Resusc. 2009 Sep;11(3):180-3.PMID: 19737119 [PubMed - indexed for MEDLINE]Related articles

    6.

    Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent.

    Larrede S, Quinn CM, Jessup W, Frisdal E, Olivier M, Hsieh V, Kim MJ, Van Eck M, Couvert P, Carrie A, Giral P, Chapman MJ, Guerin M, Le Goff W.

    Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1930-6. Epub 2009 Sep 3.PMID: 19729607 [PubMed - in process]Related articles

    7.

    Glucose absorption and gastric emptying in critical illness.

    Chapman MJ, Fraser RJ, Matthews G, Russo A, Bellon M, Besanko LK, Jones KL, Butler R, Chatterton B, Horowitz M.

    Crit Care. 2009;13(4):R140. Epub 2009 Aug 27.PMID: 19712450 [PubMed - in process]Related articlesFree article

    8.

    Prokinetic drugs for feed intolerance in critical illness: current and potential therapies.

    Deane AM, Fraser RJ, Chapman MJ.

    Crit Care Resusc. 2009 Jun;11(2):132-43. Review.PMID: 19485878 [PubMed - indexed for MEDLINE]Related articles

    9.

    Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl.

    Chantepie S, Malle E, Sattler W, Chapman MJ, Kontush A.

    Arch Biochem Biophys. 2009 Jul 1;487(1):28-35. Epub 2009 May 21.PMID: 19464255 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.

    Deane AM, Chapman MJ, Fraser RJ, Burgstad CM, Besanko LK, Horowitz M.

    Crit Care. 2009;13(3):R67. Epub 2009 May 13.PMID: 19439067 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.

    Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Pirault J, Deswaerte V, Ginhoux F, Miller ER, Witztum JL, Chapman MJ, Lesnik P.

    Circulation. 2009 May 5;119(17):2367-75. Epub 2009 Apr 20.PMID: 19380622 [PubMed - indexed for MEDLINE]Related articles

    12.

    Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha. Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice.

    Prieur X, Lesnik P, Moreau M, Rodríguez JC, Doucet C, Chapman MJ, Huby T.

    Biochim Biophys Acta. 2009 Aug;1791(8):764-71. Epub 2009 Apr 9.PMID: 19362162 [PubMed - indexed for MEDLINE]Related articles

    13.

    Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

    Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):870-6. Epub 2009 Mar 26.PMID: 19325143 [PubMed - indexed for MEDLINE]Related articles

    14.

    Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage.

    Gautier EL, Huby T, Witztum JL, Ouzilleau B, Miller ER, Saint-Charles F, Aucouturier P, Chapman MJ, Lesnik P.

    Circulation. 2009 Apr 7;119(13):1795-804. Epub 2009 Mar 23.PMID: 19307478 [PubMed - indexed for MEDLINE]Related articles

    15.

    Femoral-radial arterial pressure gradients in critically ill patients.

    Galluccio ST, Chapman MJ, Finnis ME.

    Crit Care Resusc. 2009 Mar;11(1):34-8.PMID: 19281442 [PubMed - indexed for MEDLINE]Related articles

    16.

    Small, dense HDL3 particles attenuates apoptosis in endothelial cells: Pivotal role of apolipoprotein A-I.

    de Souza JA, Vindis C, Nègre-Salvayre A, Rye KA, Couturier M, Therond P, Chantepie S, Salvayre R, Chapman MJ, Kontush A.

    J Cell Mol Med. 2009 Feb 20. [Epub ahead of print]PMID: 19243471 [PubMed - as supplied by publisher]Related articles

    17.

    A machine-learning approach to the prediction of oxidative stress in chronic inflammatory disease.

    de la Villehuchet AM, Brack M, Dreyfus G, Oussar Y, Bonnefont-Rousselot D, Chapman MJ, Kontush A.

    Redox Rep. 2009;14(1):23-33.PMID: 19161675 [PubMed - indexed for MEDLINE]Related articles

    18.

    Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.

    MacDonald ML, van Eck M, Hildebrand RB, Wong BW, Bissada N, Ruddle P, Kontush A, Hussein H, Pouladi MA, Chapman MJ, Fievet C, van Berkel TJ, Staels B, McManus BM, Hayden MR.

    Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):341-7. Epub 2008 Dec 18.PMID: 19095997 [PubMed - indexed for MEDLINE]Related articles

    19.

    Following up fighting fit: the long-term impact of health practitioner input on obesity and BMI amongst adults with intellectual disabilities.

    Chapman MJ, Craven MJ, Chadwick DD.

    J Intellect Disabil. 2008 Dec;12(4):309-23.PMID: 19074936 [PubMed - indexed for MEDLINE]Related articles

    20.

    The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.

    Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P.

    Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K. Review.PMID: 19068318 [PubMed - indexed for MEDLINE]Related articles

    21.

    Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway.

    Catalano G, Julia Z, Frisdal E, Vedie B, Fournier N, Le Goff W, Chapman MJ, Guerin M.

    Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):268-75. Epub 2008 Nov 26.PMID: 19038848 [PubMed - indexed for MEDLINE]Related articles

    22.

    The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.

    Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P; Residual Risk Reduction Initiative (R3I).

    Diab Vasc Dis Res. 2008 Nov;5(4):319-35. Review.PMID: 18958843 [PubMed - indexed for MEDLINE]Related articles

    23.

    Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy.

    Couvert P, Giral P, Dejager S, Gu J, Huby T, Chapman MJ, Bruckert E, Carrié A.

    Pharmacogenomics. 2008 Sep;9(9):1217-27.PMID: 18781850 [PubMed - indexed for MEDLINE]Related articles

    24.

    The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics.

    Hall RC, Hall RC, Chapman MJ.

    Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):446-52. Epub 2008 Jul 23.PMID: 18774428 [PubMed - indexed for MEDLINE]Related articles

    25.

    [Contribution of NMR to the assessment of dyslipidemia-related cardiovascular risk]

    Bonnefont-Rousselot D, Bittar R, Atassi M, Bruckert E, Chapman MJ.

    Ann Pharm Fr. 2008 Jun;66(3):123-8. Epub 2008 Jun 20. Review. French. PMID: 18706340 [PubMed - indexed for MEDLINE]Related articles

    26.

    HDL: close to our memories?

    Kontush A, Chapman MJ.

    Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1418-20. No abstract available. PMID: 18650505 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.

    Bergmark C, Dewan A, Orsoni A, Merki E, Miller ER, Shin MJ, Binder CJ, Hörkkö S, Krauss RM, Chapman MJ, Witztum JL, Tsimikas S.

    J Lipid Res. 2008 Oct;49(10):2230-9. Epub 2008 Jul 1.PMID: 18594118 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock.

    Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Chapman MJ, Lesnik P.

    J Immunol. 2008 May 15;180(10):6941-6.PMID: 18453615 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients.

    Nguyen NQ, Fraser RJ, Bryant LK, Burgstad C, Chapman MJ, Bellon M, Wishart J, Holloway RH, Horowitz M.

    Crit Care Med. 2008 May;36(5):1469-74.PMID: 18434906 [PubMed - indexed for MEDLINE]Related articles

    30.

    Spotlight on HDL-raising therapies: insights from the torcetrapib trials.

    Kontush A, Guérin M, Chapman MJ.

    Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):329-36. Epub 2008 Apr 22. Review.PMID: 18431367 [PubMed - indexed for MEDLINE]Related articles

    31.

    Why is HDL functionally deficient in type 2 diabetes?

    Kontush A, Chapman MJ.

    Curr Diab Rep. 2008 Feb;8(1):51-9. Review.PMID: 18366999 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.

    Chapman MJ, Sposito AC.

    Pharmacol Ther. 2008 Mar;117(3):354-73. Epub 2007 Dec 14. Review.PMID: 18215759 [PubMed - indexed for MEDLINE]Related articles

    33.

    Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome.

    Giral P, Jacob N, Dourmap C, Hansel B, Carrié A, Bruckert E, Girerd X, Chapman MJ.

    Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):587-93. Epub 2008 Jan 17.PMID: 18202323 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patients.

    Nguyen NQ, Fraser RJ, Bryant LK, Chapman MJ, Wishart J, Holloway RH, Butler R, Horowitz M.

    Crit Care. 2007;11(6):R132.PMID: 18154642 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Gastric emptying and the organization of antro-duodenal pressures in the critically ill.

    Chapman MJ, Fraser RJ, Bryant LK, Vozzo R, Nguyen NQ, Tam W, Zacharakis B, Davidson G, Butler R, Horowitz M.

    Neurogastroenterol Motil. 2008 Jan;20(1):27-35. Epub 2007 Dec 7.PMID: 18069967 [PubMed - indexed for MEDLINE]Related articles

    36.

    The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illness.

    Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Burgstad C, Ching K, Bellon M, Holloway RH.

    Intensive Care Med. 2008 Mar;34(3):454-60. Epub 2007 Dec 4.PMID: 18060542 [PubMed - indexed for MEDLINE]Related articles

    37.

    Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects.

    Catalano G, Duchene E, Julia Z, Le Goff W, Bruckert E, Chapman MJ, Guerin M.

    J Lipid Res. 2008 Mar;49(3):635-43. Epub 2007 Dec 5.PMID: 18057374 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Metabolic syndrome and type 2 diabetes: lipid and physiological consequences.

    Chapman MJ.

    Diab Vasc Dis Res. 2007 Sep;4 Suppl 3:S5-8.PMID: 17935058 [PubMed - indexed for MEDLINE]Related articles

    39.

    Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1.

    Out R, Jessup W, Le Goff W, Hoekstra M, Gelissen IC, Zhao Y, Kritharides L, Chimini G, Kuiper J, Chapman MJ, Huby T, Van Berkel TJ, Van Eck M.

    Circ Res. 2008 Jan 4;102(1):113-20. Epub 2007 Oct 25.PMID: 17967783 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia.

    Guerin M, Le Goff W, Duchene E, Julia Z, Nguyen T, Thuren T, Shear CL, Chapman MJ.

    Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):148-54. Epub 2007 Oct 19.PMID: 17951324 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.

    de Souza JA, Vindis C, Hansel B, Nègre-Salvayre A, Therond P, Serrano CV Jr, Chantepie S, Salvayre R, Bruckert E, Chapman MJ, Kontush A.

    Atherosclerosis. 2008 Mar;197(1):84-94. Epub 2007 Sep 14.PMID: 17868679 [PubMed - indexed for MEDLINE]Related articles

    42.

    Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective.

    Roze S, Ferrières J, Bruckert E, Van Ganse E, Chapman MJ, Liens D, Renaudin C.

    Int J Clin Pract. 2007 Nov;61(11):1805-11. Epub 2007 Sep 10.PMID: 17850322 [PubMed - indexed for MEDLINE]Related articles

    43.

    Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia.

    Hansel B, Nicolle C, Lalanne F, Tondu F, Lassel T, Donazzolo Y, Ferrières J, Krempf M, Schlienger JL, Verges B, Chapman MJ, Bruckert E.

    Am J Clin Nutr. 2007 Sep;86(3):790-6.PMID: 17823447 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Efficacy of the CathRite system to guide bedside placement of peripherally inserted central venous catheters in critically ill patients: a pilot study.

    Hockley SJ, Hamilton V, Young RJ, Chapman MJ, Taylor J, Creed S, Chorley DP, Williams DB, de M Tippett M.

    Crit Care Resusc. 2007 Sep;9(3):251-5.PMID: 17767451 [PubMed - indexed for MEDLINE]Related articles

    45.

    Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance.

    Nguyen NQ, Ching K, Fraser RJ, Chapman MJ, Holloway RH.

    Intensive Care Med. 2008 Jan;34(1):169-73. Epub 2007 Aug 15.PMID: 17701160 [PubMed - indexed for MEDLINE]Related articles

    46.

    Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

    Deane A, Chapman MJ, Fraser RJ, Bryant LK, Burgstad C, Nguyen NQ.

    World J Gastroenterol. 2007 Aug 7;13(29):3909-17. Review.PMID: 17663503 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.

    Kontush A, Therond P, Zerrad A, Couturier M, Négre-Salvayre A, de Souza JA, Chantepie S, Chapman MJ.

    Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1843-9. Epub 2007 Jun 14.PMID: 17569880 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice.

    Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy G, Chapman MJ, Lesnik P.

    Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1625-31. Epub 2007 Apr 19.PMID: 17446440 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis.

    Nieuwdorp M, Holleman F, de Groot E, Vink H, Gort J, Kontush A, Chapman MJ, Hutten BA, Brouwer CB, Hoekstra JB, Kastelein JJ, Stroes ES.

    Diabetologia. 2007 Jun;50(6):1288-93. Epub 2007 Apr 6.PMID: 17415544 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Gastrointestinal motility and prokinetics in the critically ill.

    Chapman MJ, Nguyen NQ, Fraser RJ.

    Curr Opin Crit Care. 2007 Apr;13(2):187-94. Review.PMID: 17327741 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...